30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675)

T J Haller, X L Yin, T J O'Byrne, E J Moore,D J Ma, K P Price,S H Patel, M L Hinni,M A Neben-Wittich,L A McGee, D L Price, J R Janus, J K Kasperbauer, T H Nagel,D M Routman,S C Lester, J C M Rwigema,A V Chintakuntlawar, P S Savvides,J J Garcia,R L Foote,K M Van Abel

Oral Oncology（2023）

引用 2|浏览35

暂无评分

摘要

•Study evaluating postoperative course after TORS oropharyngeal resection.•Clinical trial patients receiving deescalated adjuvant therapy for HPV(+)OPSCC.•Patients had acceptable post-operative bleeding rates requiring intervention (4.6%)•There were very low rates of postoperative complication.

查看译文

关键词

Transoral robotic surgery,TORS,De-escalation,Radiation,Chemotherapy,Oropharynx cancer,Oropharyngeal squamous cell carcinoma,Human papillomavirus,HPV,Hemorrhage

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要